sofosbuvir has been researched along with Pregnancy in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 11 (64.71) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Z; Chen, Z; Gao, D; Khan, IM; Luo, L; Tong, X; Wang, Y; Xu, T; Zhang, D; Zhang, L; Zhang, M; Zhang, Y | 1 |
| Chen, ZM; Cui, GL; Dong, XP; Ji, F; Lv, J; Wang, B; Yu, ZJ; Zeng, QL; Zhang, HX | 1 |
| Gowda, C; Honegger, JR | 1 |
| Hon, KLE; Leung, AKC; Sridhar, S; Wong, AHC | 1 |
| Abdel-Aziz, MM; Hafez, HA; Kamel, MA; Khafaga, RHM; Mahmoud, SA; Shaker, SA | 1 |
| Alhmoud, JF; Hafez, HA; Kamel, MA; Khafaga, RHM; Mahmoud, SA; Shaker, SA | 1 |
| Mandimika, C; Ogbuagu, O | 1 |
| Alves, AMB; Andrade, MCR; Bentes, GA; Bottino, FO; Castro, MP; Fonseca, LB; Freire, MS; Gardinali, NR; Kugelmeier, T; Lima, SMB; Linhares, JHR; Lopes, CAA; Marchevsky, RS; Melgaço, JG; Miranda, EH; Moran, J; Motta, MCVA; Nudelman, RF; Oliveira, JM; Pelajo-Machado, M; Perea, JAS; Pereira, HM; Pinto, DP; Pinto, MA; Salvador Castro Faria, SB; Sarges, K; Schmidt-Chanasit, J; Silva, ACA; Silva, MCC; Silva, SA; Soares-Bezerra, RJ; Soriano, A; Souza, TML; Trindade, GF; Vilhena, LS | 1 |
| Burger, DM; Colbers, A; Drenth, JPH; Freriksen, JJM; Greupink, R; Meijerhof, M; Russel, FGM; van Drongelen, J | 1 |
| Bogen, DL; Bunge, KE; Chappell, CA; Gaggar, A; Hillier, SL; Kirby, BJ; Krans, EE; Macio, IS; Meyn, LA; Scarsi, KK; Suri, V | 1 |
| Antala, S; Grobman, WA; Jhaveri, R; Murphy, M; Shah, SK; Yee, LM | 1 |
| AbdAllah, M; Abdel-Razek, W; Alalfy, M; Alboraie, M; Ammar, I; Doss, W; El Akel, W; El-Bendary, M; El-Sayed, MH; El-Serafy, M; Elbaz, T; Esmat, G; Gomaa, A; Hassany, M; Hefny, Z; Kamal, E; Okasha, A; Shaaban, E | 1 |
| Fraser, H; Havens, JR; Hoven, A; Lofwall, M; Schaninger, T; Staton, M; Vickerman, P; Walsh, SL; Young, AM | 1 |
| Goebel, S; Kalkeri, R; Koide, F; Ptak, R; Snyder, B | 1 |
| Brown, RS; Camus, G; Copans, A; Ghali, P; Guyer, B; Haubrich, R; Kang, M; Luetkemeyer, AF; Mantry, PS; Ni, L; Rossaro, L; Satapathy, SK; Shen, X; Tam, E | 1 |
| Cervino, L; Hynicka, LM | 1 |
| Domalakes, E; He, L; Lee, GT; Mason, CW; Parrott, J; Pfeifer, E; Zhou, H | 1 |
2 review(s) available for sofosbuvir and Pregnancy
| Article | Year |
|---|---|
Defer no more: advances in the treatment and prevention of chronic hepatitis C virus infection in children.
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Female; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Infant, Newborn; Pregnancy; Sofosbuvir | 2022 |
Hepatitis E virus and Zoonosis: Recent Advances and Therapeutic Implications.
Topics: Animals; Female; Hepatitis A; Hepatitis E; Hepatitis E virus; Humans; Pregnancy; Rats; Ribavirin; Sofosbuvir; Zoonoses | 2023 |
3 trial(s) available for sofosbuvir and Pregnancy
| Article | Year |
|---|---|
Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study.
Topics: Antiviral Agents; Benzimidazoles; Drug Therapy, Combination; Female; Fluorenes; Genotype; Hepacivirus; Hepatitis C; Humans; Infant; Pregnancy; Pregnant Women; Sofosbuvir; Treatment Outcome | 2020 |
Eliminating hepatitis C in a rural Appalachian county: protocol for the Kentucky Viral Hepatitis Treatment Study (KeY Treat), a phase IV, single-arm, open-label trial of sofosbuvir/velpatasvir for the treatment of hepatitis C.
Topics: Antiviral Agents; Carbamates; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Heterocyclic Compounds, 4 or More Rings; Humans; Kentucky; Pregnancy; Sofosbuvir; Treatment Outcome | 2021 |
Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir-experienced, NS5A treatment-naïve patients: Findings from two randomized trials.
Topics: Adult; Aged; Antiviral Agents; Benzimidazoles; Coinfection; Fatigue; Female; Fluorenes; Headache; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Liver Cirrhosis; Male; Middle Aged; Pregnancy; Ribavirin; Sofosbuvir; Sustained Virologic Response; Uridine Monophosphate | 2018 |
12 other study(ies) available for sofosbuvir and Pregnancy
| Article | Year |
|---|---|
Vitrification of murine mature metaphase II oocytes perturbs DNA methylation reprogramming during preimplantation embryo development.
Topics: 5-Methylcytosine; Animals; Blastocyst; Cryopreservation; Cytosine; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Embryonic Development; Female; Fertilization in Vitro; Metaphase; Mice; Morula; Oocytes; Oogenesis; Pregnancy; Proto-Oncogene Proteins; Vitrification | 2019 |
Sofosbuvir-based therapy for late pregnant women and infants with severe chronic hepatitis C: A case series study.
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Fluorenes; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Infant, Newborn; Pregnancy; Pregnant Women; Sofosbuvir; Treatment Outcome | 2022 |
The pre-conception maternal exposure to Sofosbuvir affects the mitochondrial biogenesis in prenatal fetal tissues: Experimental study on rats.
Topics: Animals; DNA, Mitochondrial; Female; Fetus; Genotype; Hepatitis C; Humans; Male; Maternal Exposure; Organelle Biogenesis; Placenta; Pregnancy; Rats; Sofosbuvir | 2023 |
The Intergeneration Long-Lasting Consequences of Pre-Conceptional Exposure to Sofosbuvir on the Ovarian Tissues of F1 Offspring: Experimental Study on Rats.
Topics: Animals; Cell Communication; Female; Fertilization; Hepatitis C; Humans; Male; Pregnancy; Rats; Reproduction; Sofosbuvir | 2023 |
Successful sofosbuvir lead-in monotherapy for the treatment of hepatitis C virus (HCV) infection in a pregnant woman living with HIV.
Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Carbamates; Female; Hepatitis C; Herpes Genitalis; Heterocyclic Compounds, 4 or More Rings; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Sofosbuvir | 2019 |
Sofosbuvir shows a protective effect against vertical transmission of Zika virus and the associated congenital syndrome in rhesus monkeys.
Topics: Animals; Antibodies, Viral; Antiviral Agents; Brazil; Female; Infectious Disease Transmission, Vertical; Macaca mulatta; Pregnancy; Pregnancy Complications, Infectious; Sofosbuvir; Translational Research, Biomedical; Viremia; Zika Virus; Zika Virus Infection | 2020 |
Transfer of daclatasvir and sofosbuvir's main metabolite, GS-331007, across the human placenta ex vivo.
Topics: Antiviral Agents; Carbamates; Female; Hepatitis C; Humans; Imidazoles; Maternal-Fetal Exchange; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pyrrolidines; Sofosbuvir; Uridine; Valine | 2020 |
Responsible Inclusion of Pregnant Individuals in Eradicating HCV.
Topics: Antiviral Agents; Benzimidazoles; Biomedical Research; Female; Fluorenes; Hepatitis C, Chronic; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Sofosbuvir | 2021 |
Pregnancy outcome of anti-HCV direct-acting antivirals: Real-life data from an Egyptian cohort.
Topics: Antiviral Agents; Drug Therapy, Combination; Egypt; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Infant, Newborn; Pregnancy; Pregnancy Outcome; Ribavirin; Sofosbuvir; Sustained Virologic Response; Treatment Outcome | 2021 |
Synergistic antiviral activity of Sofosbuvir and type-I interferons (α and β) against Zika virus.
Topics: Africa; Antiviral Agents; Asia; Cell Line, Tumor; Cytoprotection; Female; Fluorescent Antibody Technique; Hepatocytes; Humans; Interferon-alpha; Interferon-beta; Pregnancy; Proof of Concept Study; Sofosbuvir; Zika Virus; Zika Virus Infection | 2018 |
Direct-Acting Antivirals to Prevent Vertical Transmission of Viral Hepatitis C: When Is the Optimal Time to Treat?
Topics: Antiviral Agents; Drug Administration Schedule; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Ribavirin; Sofosbuvir; Time Factors | 2018 |
Regulation of human placental drug transporters in HCV infection and their influence on direct acting antiviral medications.
Topics: Antiviral Agents; ATP-Binding Cassette Transporters; Biological Transport; Female; Guanine; Hepatitis C; Humans; Placenta; Pregnancy; Sofosbuvir; Solute Carrier Proteins; Tenofovir; Trophoblasts | 2018 |